Cargando…
Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study
BACKGROUND: Antipsychotic (AP) polypharmacy (APP), the coprescription of more than 1 AP, is frequently practiced in psychiatric inpatients and is considered to be a risk factor for adverse drug events (ADEs). However, the association between APP and ADEs among psychiatric inpatients has not been wel...
Autores principales: | Ayani, Nobutaka, Morimoto, Takeshi, Sakuma, Mio, Kikuchi, Toshiaki, Watanabe, Koichiro, Narumoto, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244930/ https://www.ncbi.nlm.nih.gov/pubmed/34108429 http://dx.doi.org/10.1097/JCP.0000000000001416 |
Ejemplares similares
-
The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study
por: Ayani, Nobutaka, et al.
Publicado: (2016) -
Epidemiology of adverse drug events and medication errors in four nursing homes in Japan: the Japan Adverse Drug Events (JADE) Study
por: Ayani, Nobutaka, et al.
Publicado: (2022) -
Improving the assessment of adverse drug reactions using the Naranjo Algorithm in daily practice: The Japan Adverse Drug Events Study
por: Murayama, Hiroki, et al.
Publicado: (2018) -
The Burden of Preventable Adverse Drug Events on Hospital Stay and Healthcare Costs in Japanese Pediatric Inpatients: The JADE Study
por: Iwasaki, Hitoshi, et al.
Publicado: (2021) -
Using INTERCheck(®) to Evaluate the Incidence of Adverse Events and Drug–Drug Interactions in Out- and Inpatients Exposed to Polypharmacy
por: Martocchia, Antonio, et al.
Publicado: (2020)